POTO, REMO
 Distribuzione geografica
Continente #
NA - Nord America 537
AS - Asia 257
EU - Europa 249
AF - Africa 12
OC - Oceania 1
SA - Sud America 1
Totale 1.057
Nazione #
US - Stati Uniti d'America 520
IT - Italia 139
SG - Singapore 138
HK - Hong Kong 89
DE - Germania 38
CA - Canada 17
NL - Olanda 13
BG - Bulgaria 12
CI - Costa d'Avorio 11
IE - Irlanda 11
IN - India 11
FI - Finlandia 10
GB - Regno Unito 8
CN - Cina 7
UA - Ucraina 6
RU - Federazione Russa 5
FR - Francia 4
TW - Taiwan 4
VN - Vietnam 4
PK - Pakistan 2
AU - Australia 1
BD - Bangladesh 1
BE - Belgio 1
BR - Brasile 1
IR - Iran 1
LT - Lituania 1
SE - Svezia 1
UG - Uganda 1
Totale 1.057
Città #
Singapore 115
Hong Kong 89
Chandler 75
Santa Clara 50
Ashburn 49
Naples 37
Lawrence 22
Menlo Park 19
Millbury 18
Boston 14
Napoli 12
Seattle 12
Sofia 12
Wilmington 12
Des Moines 10
Krefeld 10
Rome 10
Amsterdam 8
Pune 8
Lappeenranta 6
Vancouver 6
Formia 5
Ottawa 5
Woodbridge 5
Council Bluffs 4
Dong Ket 4
Gravina in Puglia 4
Helsinki 4
Houston 4
London 4
Milan 4
Rottweil 4
San Mateo 4
Toronto 4
Tramonti 4
Caserta 3
Douliu 3
Fairfield 3
Brescia 2
Dublin 2
Ercolano 2
Karlsruhe 2
Kronberg 2
Lahore 2
Marano di Napoli 2
Piscataway 2
Redmond 2
Vailate 2
Angri 1
Augusta 1
Bad Bellingen 1
Beijing 1
Boardman 1
Bologna 1
Boscoreale 1
Bromley 1
Camerino 1
Campagna 1
Chengdu 1
Clifton 1
Dalian 1
Feni 1
Frankfurt am Main 1
Freiburg im Breisgau 1
Groningen 1
Guangzhou 1
Kampala 1
Langley 1
Los Angeles 1
Maasmechelen 1
Macerata Campania 1
Modena 1
Montesarchio 1
Montréal 1
Moscow 1
Mugnano Di Napoli 1
New York 1
Norwalk 1
Paris 1
Portici 1
Recife 1
Salerno 1
San Diego 1
Sarno 1
Spresiano 1
St Petersburg 1
Stockholm 1
Sydney 1
Uhlingen-Birkendorf 1
Venice 1
Verona 1
Vicenza 1
Villeurbanne 1
Totale 727
Nome #
Differential Effects of Alarmins on Human and Mouse Basophils 47
The immunology of switching biologics in severe eosinophilic asthma patients 44
Oxidative stress in anticancer therapies-related cardiac dysfunction 41
Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series 41
Human Lung Mast Cells: Therapeutic Implications in Asthma 39
Liver stiffness assessment by transient elastography suggests high prevalence of liver involvement in common variable immunodeficiency 39
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors 39
Gut Microbiome and Common Variable Immunodeficiency: Few Certainties and Many Outstanding Questions. (VARRICCHI PRIMO AUTORE E AUTORE CORRISPONDENTE) 39
SARS-CoV-2 Spike Protein Activates Human Lung Macrophages 36
Heterogeneity of human mast cells with respect to MRGPRX2 receptor expression and function. (VARRICCHI PRIMO AUTORE E AUTORE CORRISPONDENTE) 36
How can we manage the cardiac toxicity of immune checkpoint inhibitors? 35
IgG Autoantibodies Against IgE from Atopic Dermatitis Can Induce the Release of Cytokines and Proinflammatory Mediators from Basophils and Mast Cells 35
Angiogenesis, Lymphangiogenesis, and Inflammation in Chronic Obstructive Pulmonary Disease (COPD): Few Certainties and Many Outstanding Questions 33
Gender dimorphism in IgA subclasses in T2-high asthma 32
Tezepelumab: a novel biological therapy for the treatment of severe uncontrolled asthma 31
Is There a Role for Basophils in Cancer? 31
Can FeNO be a biomarker in the post-COVID-19 patients monitoring? 30
The emerging role of T follicular helper (TFH) cells in aging: Influence on the immune frailty. (VARRICCHI PRIMO AUTORE E AUTORE CORRISPONDENTE) 28
Neutrophil extracellular traps and neutrophil-derived mediators as possible biomarkers in bronchial asthma 28
IL-33 and Superantigenic Activation of Human Lung Mast Cells Induce the Release of Angiogenic and Lymphangiogenic Factors. (VARRICCHI ULTIMO AUTORE E AUTORE CORRISPONDENTE) 27
Neutrophil Extracellular Traps, Angiogenesis and Cancer 26
Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study 25
Holistic Approach to Immune Checkpoint Inhibitor-Related Adverse Events 25
Evaluation of exercise capacity by means of cardiopulmonary exercise testing (CPET) in older adult cancer patients undergoing antineoplastic treatments 24
The broad spectrum of cardiotoxicities from immunotherapies 23
Autoantibodies to IgE can induce the release of proinflammatory and vasoactive mediators from human cardiac mast cells 23
IL-3 in the development and function of basophils 21
Angiopoietins, vascular endothelial growth factors and secretory phospholipase A2 in heart failure patients with preserved ejection fraction 20
Thymic Stromal Lymphopoietin (TSLP) Is Cleaved by Human Mast Cell Tryptase and Chymase 19
Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID) 18
Unleashing the power of formyl peptide receptor 2 in cardiovascular disease 18
Imaging of chronic rhinosinusitis with nasal polyps in the era of biological therapies 17
Correction to: Is there a role for microbiome‑based approach in common variable immunodeficiency? 16
Neutrophil Extracellular Traps in Asthma: Friends or Foes? 16
Basophils from allergy to cancer 16
Is there a role for microbiome-based approach in common variable immunodeficiency? 15
Thymic stromal lymphopoietin (TSLP) is a substrate for tryptase in patients with mastocytosis 15
Neutrophil extracellular traps and neutrophil-related mediators in human thyroid cancer 14
The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cells 14
TSLP is localized in and released from human lung macrophages activated by T2-high and T2-low stimuli: relevance in asthma and COPD 13
Mast cells: a novel therapeutic avenue for cardiovascular diseases? 11
Biologics and airway remodeling in asthma: early, late, and potential preventive effects 10
Basophils beyond allergic and parasitic diseases 10
The Role of Gut Microbiota and Leaky Gut in the Pathogenesis of Food Allergy 10
Mepolizumab reduces nasal symptoms in asthmatic patients with chronic rhino-sinusitis and nasal polyposis: a 12 months real-life study 9
Towards precision medicine in COPD: Targeting type 2 cytokines and alarmins 8
Biologics and airway remodeling in severe asthma 8
Totale 1.155
Categoria #
all - tutte 7.309
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.309


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202015 0 0 0 0 0 0 0 0 10 0 2 3
2020/202141 4 0 0 5 0 0 11 3 2 7 4 5
2021/2022209 3 8 15 13 10 0 2 13 0 14 56 75
2022/2023261 28 11 9 5 33 27 26 40 31 14 24 13
2023/2024254 5 35 33 26 9 37 14 27 9 11 30 18
2024/2025367 68 65 1 7 24 92 110 0 0 0 0 0
Totale 1.155